Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Prostatic Neoplasms 10Metastatic Castration-resistant Prostate Cancer 2Prostatic Neoplasms, Castration-Resistant 1Metastatic Hormone Naive Prostate Cancer 1Metastatic Castration Resistant Prostate Cancer (mCRPC) 1Kidney Neoplasms 1Carcinoma, Renal Cell 1

Interventions

Pluvicto 1Docetaxel 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Active not recruiting × Metastatic Hormone Naive Prostate Cancer × Pluvicto × Clear all
NCT04343885 2025-07-11

UpFrontPSMA

Peter MacCallum Cancer Centre, Australia

Phase 2 Active not recruiting
130 enrolled
Genitourinary

Metastatic Hormone Naive Prostate Cancer

Data powered by HemOnc (CC BY 4.0) Colophon âš¡